Bovril and moclobemide: a novel therapeutic strategy for central autonomic failure.
case_report · Level V
Where this comes from
- Record sourced from PubMed, PMID 7967987.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
The consumption of tyramine-containing foods is contraindicated in patients on classic monoamine oxidase (MAO) inhibitors. We report successful therapeutic use of moclobemide (a MAO-A selective inhibitor) plus controlled amounts of Bovril (a tyramine-rich yeast-extract available as a food) in a patient with pure central autonomic failure who was rendered bed-bound by severe postural hypotension. Standing blood pressure is now at least 90/45 mm Hg. The selectivity of moclobemide allows about a tenth of ingested tyramine to reach nerve endings and thus the modest hypertensive effect of this combination re-established day-to-day function by restoring normotension.
Medical subject headings
- Autonomic Nervous System Diseases
- Benzamides
- Hypotension, Orthostatic
- Monoamine Oxidase Inhibitors
- Tyramine
- Yeast, Dried